Experiment 67017

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationWITTE,RS: LIPSITZ,S: GOODMAN,TL: ASBURY,RF: WILDING,G: STRNAD,CM: SMITH,TJ: HALLER,DG:. (1999). A PHASE II TRIAL OF HOMOHARRINGTONINE AND CARACEMIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED LARGE BOWEL CANCER.. 17(2)
Amount utilized
Compound isolated
Disease13 PATIENTS; AGE RANGE IS 21-83 AND MEDIAN IS 59 OLD YRS; 5 FEMALE AND 8 MALE; DISEASE SITE: 8 PATIENTS IN LIVER AND 5 PATIENTS IN PULMONARY; THE MEDIAN TIME TO TREATMENT FAILURE WAS 1.8 MONTHS. OF NOTE, THE DRUG WAS CLOSED PREMATURELY DUE TO TOXICITY.
Number1
Qualitative resultEQUIVOCAL
AnimalHUMAN ADULT
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES